BailarJCByarDP. Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilboestrol and placebo. Cancer1970; 26: 257.
2.
HurstKSByarD. An analysis of the effects of changes from the assigned treatment for prostatic cancer. J Chronic Dis1970; 26: 311.
3.
HawkinsEFNijsMBrassineCTagnonHJ. Steroid receptors in the human prostate. 1. Estradiol-17 β binding in benign prostatic hypertrophy. Steroids1975; 26: 458–469.
4.
WagnerRKSchulzeKHJungblutPW. Estrogen and androgen receptor in human prostate and prostatic tumour tissue. Acta Endocrinol suppl (Copenh)1975; 193: 52.
5.
MorganLRPoseyLELanasaJ. Therapeutic use of ‘Nolvadex’ (tamoxifen, ICI 46, 474) in advanced prostatic cancer. Proceedings of 12th Int. Cancer Congress, Buenos Aires, 5–11th October 1978. W51: 111.
6.
GlickJWeinANegendankWTamoxifen in metastatic prostate and renal cancer. Proc Am Assoc Cancer Res - Am Soc Clin Oncol1979; 20: Abstr C-81.
7.
LeghaSMuggiaF. Antiestrogens in the treatment of cancer. Ann Intern Med1976; 85: 751.
8.
TismanGKellonDBWuSSafireGE. Use of tamoxifen in tumours other than breast cancer. Clin Res1976; 24: 381a.
9.
El-AriniM Osama. Response to tamoxifen in drug-resistant prostatic carcinoma. Lancet1979; 2: 588.
10.
ComhaireF. Treatment of oligospermia with tamoxifen. Int J Fertil1976; 21: 232.
11.
ComhaireF. Hormonal effects of an anti-oestrogen, tamoxifen, in normal and oligos-permic men. Fertil Steril1978; 29: 320.
